Identifying Disease Mechanisms and Therapeutic Opportunities in Pediatric Low-grade Gliomas Driven by MYB-QKI Fusions |
Dana-Farber Cancer Institute / Cecile Rouleau, PhD |
Young Investigator Grants |
2017 |
Massachusetts |
Role of N6-Methyladenosine (m6A) mRNA Modification Pathway in Neuroblastoma |
Boston Children’s Hospital / Shuibin Lin, PhD |
Young Investigator Grants |
2017 |
Massachusetts |
Development and Characterization of Novel Models of Human Osteosarcoma Development and Metastasis |
University of Minnesota / Beau Webber, PhD |
Young Investigator Grants |
2017 |
Minnesota |
High-Throughput Gene-Editing via Microfluidic Cell Deformability to Enable Off-the-Shelf Allogeneic Cellular Immunotherapies |
University of California, Los Angeles / Steven Jonas, MD/PhD |
Young Investigator Grants |
2017 |
California |
Epigenomic Mechanisms of Neuroblastoma Tumorigenesis |
Children’s Hospital of Philadelphia / Jo Lynne Harenza, PhD |
Young Investigator Grants |
2017 |
Pennsylvania |
End-of-Life Care of Children with Cancer: Variation and Stakeholder Priorities |
University of Alabama at Birmingham / Emily Johnston, MD |
Young Investigator Grants |
2017 |
Alabama |
Elucidating the Role of N-Myc in a High-risk Pediatric T Cell Leukemia |
New York University School of Medicine / Francesco Boccalatte, PhD |
Young Investigator Grants |
2017 |
New York |
Development of Novel Biomarkers for Immunotherapy in Neuroblastoma |
Columbia Institute for Cancer Genetics / Shuobo Boboila, PhD |
Young Investigator Grants |
2017 |
New York |
Predictive Modeling of MDS Disease Progression From Inherited Bone Marrow Failure Syndrome Using Novel Branching Process and Next Generation Sequencing to Improve Patient-Specific Survival |
Cleveland Clinic Foundation / Seth Corey, MD & Marek Kimmel, PhD |
Innovation Grants |
2017 |
Ohio |
Development of Nanoparticle-Encapsulated Chemo/Radio-Sensitizers for Intrathecal Delivery |
Yale School of Medicine / Ranjit S. Bindra, MD/PhD & Mark Saltzman, PhD |
Innovation Grants |
2017 |
Connecticut |